Literature DB >> 301045

On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs.

B M Peskar.   

Abstract

1. Specific radioimmunoassays for the prostaglandins E2, A2 and F2alpha were used to study the synthesis of prostaglandins by gastroscopically obtained small biopsy specimens of human gastric corpus mucosa. 2. Both prostaglandin E2 and prostaglandin F2alpha were found to be synthesized from arachidonic acid by themicrosomal fraction of human gastric mucosa. The synthesis of prostaglandin E2 exceeded that of prostagladin F2alpha by a factor of about 10. 3. Synthesis of prostaglandin A2 or prostaglandin B2 was not observed under the same incubation conditions. 4. Indometacin effectively inhibited synthesis of both prostaglandin E2 (ID50 4.2 microng/ml) and prostaglandin F2alpha (ID50 1.8 microng/ml) by human gastric mucosa, while paracetamol even in a concentration of 310 microng/ml did not influence prostaglandin synthesis. The anti-ulcer agent carbenoxolone, which has been shown to inhibit prostaglandin inactivation, at the same concentration only slightly inhibited (about 20%) prostaglandin synthesis. 5. The results support the hypothesis that the gastro-intestinal effects or side effects of several drugs are mediated by an influence on the enzymes of prostaglandin synthesis or inactivation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301045     DOI: 10.1016/0005-2760(77)90007-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.

Authors:  Sanjiv B Amin; Robert A Sinkin; J Christopher Glantz
Journal:  Am J Obstet Gynecol       Date:  2007-11       Impact factor: 8.661

2.  Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen.

Authors:  S Leyck; M J Parnham
Journal:  Agents Actions       Date:  1990-06

Review 3.  Dietary essential fatty acids and the decline in peptic ulcer disease--a hypothesis.

Authors:  D Hollander; A Tarnawski
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

4.  Stimulation and inhibition of prostacyclin formation in the gastric mucosa and ileum in vitro by anti-inflammatory agents.

Authors:  N K Boughton-Smith; B J Whittle
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

5.  Protection against aspirin-induced blood loss in man: assessment of a new mucolytic agent.

Authors:  W J Penny; J Rhodes; W Thomson
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

6.  Arachidonic acid does not protect against sodium taurocholate damage to rat gastric epithelial cell cultures.

Authors:  S Ota; M Razandi; A Terano; H Hiraishi; K J Ivey
Journal:  Gastroenterol Jpn       Date:  1987-06

7.  Papaverine stimulation of prostaglandin E2 production by cultured rabbit gastric mucosa.

Authors:  M Ligumsky; D Rachmilewitz; U Zor
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

8.  Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.

Authors:  A Kleine; S Kluge; B M Peskar
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

9.  Sample taking problems in measuring actual histamine levels of human gastroduodenal mucosa: specific and general relevance in clinical trials on peptic ulcer pathogenesis and selective proximal vagotomy.

Authors:  K P Thon; W Lorenz; C Ohmann; D Weber; H Rohde; H D Röher
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

10.  Diflunisal protects human gastric mucosa against damage by indomethacin.

Authors:  M M Cohen
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.